44. Leung-Pineda V, Pan Y, Chen H, Kilberg MS (2004) Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization. The Biochemical journal 379: 79–88. 45. Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and molecular biology reviews : MMBR 75: 50–83. 46. Casas-Terradellas E, Tato I, Bartrons R, Ventura F, Rosa JL (2008) ERK and p38 pathways regulate amino acid signalling. Biochimica et biophysica acta 1783: 2241–2254. 47. Janes MR, Limon JJ, So L, Chen J, Lim RJ, et al. (2010) Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nature medicine 16: 205–213. 48. Ballou LM, Selinger ES, Choi JY, Drueckhammer DG, Lin RZ (2007) Inhibition of mammalian target of rapamycin signaling by 2-(morpholin-1- yl)pyrimido[2,1-alpha]isoquinolin-4-one. The Journal of biological chemistry 282: 24463–24470. 49. Eskelinen EL, Prescott AR, Cooper J, Brachmann SM, Wang L, et al. (2002) Inhibition of autophagy in mitotic animal cells. Traffic 3: 878–893. 50. Nelsen CJ, Rickheim DG, Tucker MM, McKenzie TJ, Hansen LK, et al. (2003) Amino acids regulate hepatocyte proliferation through modulation of cyclin D1 expression. The Journal of biological chemistry 278: 25853–25858. 51. Tapon N, Moberg KH, Hariharan IK (2001) The coupling of cell growth to the cell cycle. Current opinion in cell biology 13: 731–737. 52. Kozar K, Sicinski P (2005) Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell cycle 4: 388–391. 53. Averous J, Fonseca BD, Proud CG (2008) Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1. Oncogene 27: 1106–1113. 54. Roovers K, Assoian RK (2000) Integrating the MAP kinase signal into the G1 phase cell cycle machinery. BioEssays : news and reviews in molecular, cellular and developmental biology 22: 818–826. 55. Villanueva J, Yung Y, Walker JL, Assoian RK (2007) ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Molecular biology of the cell 18: 1457–1463. CD98 Regulates Proliferation by Activating MAPKs 56. Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, et al. (2009) L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology 54: 804– 813. 57. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, et al. (2009) Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer science 100: 248–254. 58. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, et al. (2009) Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung cancer 66: 120– 126. 59. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, et al. (2008) Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Pathology, research and practice 204: 553–561. 60. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, et al. (2009) CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases. Annals of surgical oncology 16: 3473–3481. 61. Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, et al. (2008) Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I- III nonsmall cell lung cancer. British journal of cancer 98: 742–748. 62. Rauchman MI, Nigam SK, Delpire E, Gullans SR (1993) An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am J Physiol 265: F416–424. 63. Husted RF, Hayashi M, Stokes JB (1988) Characteristics of papillary collecting duct cells in primary culture. Am J Physiol 255: F1160–1169. 64. Estevez R, Camps M, Rojas AM, Tesrar X, Deves R, et al. (1998) The amino acid transport system y+L/4F2hc is a heteromultimeric complex. FASEB 12: 1319–1329. 65. Chen X, Whiting C, Borza C, Hu W, Mont S, et al. (2010) Integrin alpha1beta1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor gamma-dependent caveolin-1 expression. Molec- ular and cellular biology 30: 3048–3058. PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e40026